Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 5/2009

Open Access 01-05-2009 | Clinical Review

Obesity and Mammography: A Systematic Review and Meta-Analysis

Authors: Nisa M. Maruthur, MD, MHS, Shari Bolen, MD, MPH, Frederick L. Brancati, MD, MHS, Jeanne M. Clark, MD, MPH

Published in: Journal of General Internal Medicine | Issue 5/2009

Login to get access

Abstract

BACKGROUND

Obese women experience higher postmenopausal breast cancer risk, morbidity, and mortality and may be less likely to undergo mammography.

OBJECTIVES

To quantify the relationship between body weight and mammography in white and black women.

DATA SOURCES AND REVIEW METHODS

We identified original articles evaluating the relationship between weight and mammography in the United States through electronic and manual searching using terms for breast cancer screening, breast cancer, and body weight. We excluded studies in special populations (e.g., HIV-positive patients) or not written in English. Citations and abstracts were reviewed independently. We abstracted data sequentially and quality information independently.

RESULTS

Of 5,047 citations, we included 17 studies in our systematic review. Sixteen studies used self-reported body mass index (BMI) and excluded women <40 years of age. Using random-effects models for the six nationally representative studies using standard BMI categories, the combined odds ratios (95% CI) for mammography in the past 2 years were 1.01 (0.95 to 1.08), 0.93 (0.83 to 1.05), 0.90 (0.78 to 1.04), and 0.79 (0.68 to 0.92) for overweight (25–29.9 kg/m2), class I (30–34.9 kg/m2), class II (35–39.9 kg/m2), and class III (≥40 kg/m2) obese women, respectively, compared to normal-weight women. Results were consistent when all available studies were included. The inverse association was found in white, but not black, women in the three studies with results stratified by race.

CONCLUSIONS

Morbidly obese women are significantly less likely to report recent mammography. This relationship appears stronger in white women. Lower screening rates may partly explain the higher breast cancer mortality in morbidly obese women.
Appendix
Available only for authorised users
Literature
1.
U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2004 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2007. Available at: http://​www.​cdc.​gov/​uscs. Accessed February 6, 2009.
2.
Miller AB, Baines CJ, To T, Wall C. Canadian national breast screening study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J. 1992;147:1477–88.
3.
Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J. 1992;147:1459–98.
4.
Alexander FE, Anderson TJ, Brown HK, et al. 14 years of follow-up from the Edinburgh Randomised Trial of Breast-Cancer Screening. Lancet. 1999;353(9168):1903–8.PubMedCrossRef
5.
Tabar L, Vitak B, Chen HH, et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am. 2000;38(4):625–51.PubMedCrossRef
6.
Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359(9310):909–19.PubMedCrossRef
7.
8.
Smith RA, Cokkinides V, Eyre HJ. American cancer society guidelines for the early detection of cancer, 2006. CA Cancer J Clin. 2006;56(1):11–25. quiz 49–50.PubMedCrossRef
9.
10.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet;371(9612):569–78.
11.
Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study. BMJ. 2007;335(7630):1134.PubMedCrossRef
12.
Loi S, Milne RL, Friedlander ML, et al. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev.. 2005;14(7):1686–91.PubMedCrossRef
13.
14.
van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152(6):514–27.PubMedCrossRef
15.
Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997;278(17):1407–11.PubMedCrossRef
16.
17.
Petrelli JM, Calle EE, Rodriguez C, Thun MJ. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control. 2002;13(4):325–32.PubMedCrossRef
18.
Bastarrachea J, Hortobagyi GN, Smith TL, Kau SW, Buzdar AU. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med. 1994;120(1):18–25.PubMed
19.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–38.PubMedCrossRef
20.
Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23(7):1370–8.PubMedCrossRef
21.
Dignam JJ, Wieand K, Johnson KA, et al. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res Treat. 2006;97(3):245–54.PubMedCrossRef
22.
El-Tamer MB, Ward BM, Schifftner T, Neumayer L, Khuri S, Henderson W. Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care. Ann Surg. 2007;245(5):665–71.PubMedCrossRef
23.
Werner RS, McCormick B, Petrek J, et al. Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology. 1991;180(1):177–84.PubMed
24.
van der Veen P, De Voogdt N, Lievens P, Duquet W, Lamote J, Sacre R. Lymphedema development following breast cancer surgery with full axillary resection. Lymphology. 2004;37(4):206–8.PubMed
25.
Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL. Body mass and stage of breast cancer at diagnosis. Int J Cancer. 2002;98(2):279–83.PubMedCrossRef
26.
Chagpar AB, Mcmasters KM, Saul J, et al. Body mass index influences palpability but not stage of breast cancer at diagnosis. Am Surg. 2007;73(6):555–60.PubMed
27.
Amonkar MM, Madhavan S. Compliance rates and predictors of cancer screening recommendations among Appalachian women. J Health Care Poor Underserved. 2002;13(4):443–60.PubMedCrossRef
28.
Amy NK, Aalborg A, Lyons P, Keranen L. Barriers to routine gynecological cancer screening for White and African-American obese women. Int J Obes (Lond). 2006;30(1):147–55.CrossRef
29.
Coughlin SS, Uhler RJ, Hall HI, Briss PA. Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk? Prev Chronic Dis. 2004;1(1):A04.PubMed
30.
Fontaine KR, Heo M, Allison DB. Body weight and cancer screening among women. J Womens Health Gend Based Med. 2001;10(5):463–70.PubMedCrossRef
31.
Ostbye T, Taylor DH Jr, Yancy WS Jr, Krause KM. Associations between obesity and receipt of screening mammography, Papanicolaou tests, and influenza vaccination: results from the Health and Retirement Study (HRS) and the Asset and Health Dynamics among the Oldest Old (AHEAD) study. Am J Public Health. 2005;95(9):1623–30.PubMedCrossRef
32.
Wee CC, McCarthy EP, Davis RB, Phillips RS. Obesity and breast cancer screening. J Gen Intern Med. 2004;19(4):324–31.PubMedCrossRef
33.
Wee CC, McCarthy EP, Davis RB, Phillips RS. Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann Intern Med. 2000;132(9):697–704.PubMed
34.
Winkleby MA, Snider J, Davis B, Jennings MG, Ahn DK. Cancer-related health behaviors and screening practices among Latinos: findings from a community and agricultural labor camp survey. Ethn Dis. 2003;13(3):376–86.PubMed
35.
Zhu K, Wu H, Jatoi I, Potter J, Shriver C. Body mass index and use of mammography screening in the United States. Prev Med. 2006;42(5):381–5.PubMedCrossRef
36.
Cohen SS, Signorello LB, Gammon MD, Blot WJ. Obesity and recent mammography use among black and white women in the Southern Community Cohort Study (United States). Cancer Causes Control. 2007;18(7):765–73.PubMedCrossRef
37.
Ferrante JM, Chen PH, Crabtree BF, Wartenberg D. Cancer screening in women: body mass index and adherence to physician recommendations. Am J Prev Med. 2007;32(6):525–31.PubMedCrossRef
38.
Berz D, Sikov W, Colvin G, Weitzen S. ‘Weighing in’ on screening mammography. Breast Cancer Res Treat. 2008.
39.
Rosenberg L, Wise LA, Palmer JR, Horton NJ, Adams-Campbell LL. A multilevel study of socioeconomic predictors of regular mammography use among African-American women. Cancer Epidemiol Biomarkers Prev. 2005;14(11 Pt 1):2628–33.PubMedCrossRef
40.
Ferrante JM, Chen PH, Jacobs A. Breast and cervical cancer screening in obese minority women. J Womens Health (Larchmt). 2006;15(5):531–41.CrossRef
41.
Fontaine KR, Faith MS, Allison DB, Cheskin LJ. Body weight and health care among women in the general population. Arch Fam Med. 1998;7(4):381–4.PubMedCrossRef
42.
Gorin SS, Jacobson J. Diet and breast cancer surveillance behaviors among Harlem women. Ann N Y Acad Sci. 2001;952:153–60.PubMedCrossRef
43.
Satia JA, Galanko JA. Demographic, behavioral, psychosocial, and dietary correlates of cancer screening in African Americans. J Health Care Poor Underserved. 2007;18(4 Suppl):146–64.PubMedCrossRef
44.
45.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. The Lancet. ;370(9596):1453–7.
46.
World Health Organization. Obesity: Preventing and managing the global epidemic. Part 1: The problem of overweight and obesity. 2004;894:1–33.
47.
NHLBI Obesity Education Intiative Panel on the Identification, Treatment, and Management of Overweight and Obesity in Adults. Clinical guidelines on the identification, treatment, and management of overweight and obesity in adults. The evidence report. 1998;98–4083:1–126.
48.
49.
Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1.PubMedCrossRef
50.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.PubMedCrossRef
51.
Deeks JJ, Higgins JPT, Altman DG, editors. Analyzing and presenting results. In: Higgins JPT, Green S, editors, editors. Cochrane handbook for systematic reviews of interventions 4.2.5 [updated May 2005]; Section 8; 2005.
52.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.PubMedCrossRef
53.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.PubMed
54.
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295(13):1549–55.PubMedCrossRef
55.
Olson CL, Schumaker HD, Yawn BP. Overweight women delay medical care. Arch Fam Med. 1994;3(10):888–92.PubMedCrossRef
56.
Adams CH, Smith NJ, Wilbur DC, Grady KE. The relationship of obesity to the frequency of pelvic examination: do physician and patient attitudes make a difference? Women & health. 1993;20:45–57.CrossRef
57.
Hunt KA, Sickles EA. Effect of obesity on screening mammography: outcomes analysis of 88,346 consecutive examinations. AJR Am J Roentgenol. 2000;174(5):1251–5.PubMed
58.
Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA. 1996;276(1):33–8.PubMedCrossRef
59.
60.
Ostbye T, Yarnall KS, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med. 2005;3(3):209–14.PubMedCrossRef
61.
Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93(4):635–41.PubMedCrossRef
62.
Hebl MR, Xu J. Weighing the care: Physicians’ reactions to the size of a patient. Int J Obes Relat Metab Disord. 2001;25(8):1246–52.PubMedCrossRef
63.
Price JH, Desmond SM, Krol RA, Snyder FF, O'Connell JK. Family practice physicians’ beliefs, attitudes, and practices regarding obesity. Am J Prev Med. 1987;3(6):339–45.PubMed
64.
Teachman BA, Brownell KD. Implicit anti-fat bias among health professionals: is anyone immune? Int J Obes Relat Metab Disord. 2001;25(10):1525–31.PubMedCrossRef
65.
Stevens J, Kumanyika SK, Keil JE. Attitudes toward body size and dieting: differences between elderly black and white women. Am J Public Health. 1994;84(8):1322–5.PubMedCrossRef
66.
Anderson LA, Eyler AA, Galuska DA, Brown DR, Brownson RC. Relationship of satisfaction with body size and trying to lose weight in a national survey of overweight and obese women aged 40 and older, United States. Prev Med. 2002;35(4):390–6.PubMedCrossRef
67.
Flynn KJ, Fitzgibbon M. Body images and obesity risk among black females: a review of the literature. Ann Behav Med. 1998;20(1):13–24.PubMedCrossRef
68.
Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006;56(3):168–83.PubMedCrossRef
69.
Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005;97(6):439–48.PubMed
70.
Polednak AP. Racial differences in mortality from obesity-related chronic diseases in US women diagnosed with breast cancer. Ethn Dis. 2004;14(4):463–8.PubMed
71.
Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163(1):49–56.PubMedCrossRef
72.
Jones BA, Patterson EA, Calvocoressi L. Mammography screening in African American women: Evaluating the research. Cancer. 2003;97(1 Suppl):258–72.PubMedCrossRef
73.
Cui Y, Whiteman MK, Langenberg P, et al. Can obesity explain the racial difference in stage of breast cancer at diagnosis between black and white women? J Womens Health Gend Based Med. 2002;11(6):527–36.PubMedCrossRef
74.
Moorman PG, Jones BA, Millikan RC, Hall IJ, Newman B. Race, anthropometric factors, and stage at diagnosis of breast cancer. Am J Epidemiol. 2001;153(3):284–91.PubMedCrossRef
75.
Zhu K, Caulfield J, Hunter S, Roland CL, Payne-Wilks K, Texter L. Body mass index and breast cancer risk in African American women. Ann Epidemiol. 2005;15(2):123–8.PubMedCrossRef
76.
Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 1998;279(22):1801–7.PubMedCrossRef
77.
Lantz PM, Mujahid M, Schwartz K, et al. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health. 2006;96(12):2173–8.PubMedCrossRef
78.
Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006;144(8):541–53.PubMed
79.
McCarthy EP, Burns RB, Coughlin SS, et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med. 1998;128(9):729–36.PubMed
80.
Jones BA, Kasl SV, Curnen MG, Owens PH, Dubrow R. Can mammography screening explain the race difference in stage at diagnosis of breast cancer? Cancer. 1995;75(8):2103–13.PubMedCrossRef
81.
Jacobellis J, Cutter G. Mammography screening and differences in stage of disease by race/ethnicity. Am J Public Health. 2002;92(7):1144–50.PubMedCrossRef
82.
Gill KS, Yankaskas BC. Screening mammography performance and cancer detection among black women and white women in community practice. Cancer. 2004;100(1):139–48.PubMedCrossRef
83.
Burkhauser RV, Cawley J. Beyond BMI: The value of more accurate measures of fatness and obesity in social science research. J Health Econ. 2008 3;27(2):519–29.PubMedCrossRef
84.
Rowland ML. Self-reported weight and height. Am J Clin Nutr. 1990;52:1125–33.PubMed
85.
Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17(4):748–57.PubMedCrossRef
Metadata
Title
Obesity and Mammography: A Systematic Review and Meta-Analysis
Authors
Nisa M. Maruthur, MD, MHS
Shari Bolen, MD, MPH
Frederick L. Brancati, MD, MHS
Jeanne M. Clark, MD, MPH
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 5/2009
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-009-0939-3

Other articles of this Issue 5/2009

Journal of General Internal Medicine 5/2009 Go to the issue

Editorial

Personalizing Health Care—Is This the Right Time for Warfarin?

Original Article

Not Perfect, but Better: Primary Care Providers’ Experiences with Electronic Referrals in a Safety Net Health System

Health Policy

Who Gets Disease Management?

Original Article

Should We Test for CYP2C9 Before Initiating Anticoagulant Therapy in Patients with Atrial Fibrillation?

Brief Report

Measuring Continuing Medical Education Outcomes: A Pilot Study of Effect Size of Three CME Interventions at an SGIM Annual Meeting

Perspectives

Do New Drugs Increase Life Expectancy? A Critique of a Manhattan Institute Paper
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits